Latest Stories
3 Growth Stocks to Stash
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.
2 Growth Stocks with Explosive Upside and 1 That Underwhelm
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.
2 Stocks Under $50 to Keep an Eye On and 1 We Turn Down
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.
3 Russell 2000 Stocks We Steer Clear Of
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
3 Consumer Stocks with Warning Signs
Consumer discretionary businesses are levered to the highs and lows of economic cycles. Thankfully for the industry, demand trends seem to be healthy as discretionary stocks have gained 11.6% over the past six months. This performance has nearly mirrored the S&P 500.
1 Russell 2000 Stock to Target This Week and 2 We Find Risky
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
1 Russell 2000 Stock with Exciting Potential and 2 Facing Challenges
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
STAAR Surgical (STAA): Buy, Sell, or Hold Post Q3 Earnings?
STAAR Surgical’s 23.7% return over the past six months has outpaced the S&P 500 by 13.1%, and its stock price has climbed to $21.14 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
3 Reasons PCOR is Risky and 1 Stock to Buy Instead
Procore Technologies currently trades at $70.90 per share and has shown little upside over the past six months, posting a small loss of 1.5%. The stock also fell short of the S&P 500’s 10.6% gain during that period.
3 Reasons to Avoid MD and 1 Stock to Buy Instead
Pediatrix Medical Group has been on fire lately. In the past six months alone, the company’s stock price has rocketed 76.8%, reaching $22.67 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.